Results for Iron Metabolism

1 - 5 of 5

Dr. Rivella is an expert in the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies. He also investigates additional disorders such as anemia of inflammation and hemochromatosis.

E-mail:

rivellas [at] email.chop.edu

View Stefano Rivella's Profile

Andrew Degnan, MD, MPhil

Dr. Degnan's research and clinical training has focused on the development and application of imaging approaches to advance patient care through accurate diagnosis and improved prognostication.

E-mail:

degnana [at] email.chop.edu

View Andrew Degnan's Profile

Preclinical Testing in 3 Model Systems Suggests Some Antioxidants May Be Effective Mitochondrial Disease Treatments

Published on

Mar 27, 2018

in Press Releases

CHOP Researchers Test 7 Compounds in Seeking Candidates for Clinical Trials; Early Efficacy Seen in NAC and Vitamin E

Rivella Laboratory

The Rivella Laboratory investigates erythropoiesis, iron metabolism and inflammation and develops new therapeutics for the cure of hemoglobinopathies.

Comprehensive Center for the Cure of Sickle Cell Disease and Other Red Blood Cell Disorders

Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.